Abstract
A series of novel 5-O-(4′,6′-O-dimodified)-mycaminose 14-membered ketolides were assessed for their in vitro antibacterial activities against a panel of sensitive and resistant pathogens. Compound 1 and compound 2, two ester analogs, showed the best antibacterial activities against several macrolide-sensitive and macrolide-resistant strains. These results indicated that introducing ester to 6-OH and a small volume ether substituent to the 4-OH of mycaminose could improve the antibacterial activities of ketolides.
![](/cms/asset/21da0b5a-cb76-40c8-a18f-87b766aa2b10/ganp_a_1451519_uf0001_b.gif)
Acknowledgments
We are grateful to the Department of Instrumental Analysis of our institute for performing the NMR and mass spectroscopy measurements.